BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yee ML, Tan HH. Use of everolimus in liver transplantation. World J Hepatol 2017; 9(23): 990-1000 [PMID: 28878864 DOI: 10.4254/wjh.v9.i23.990]
URL: https://www.wjgnet.com/1948-5182/full/v9/i23/990.htm
Number Citing Articles
1
Nathanael Raschzok, Karl Herbert Hillebrandt, Igor M. Sauer. Critical Care for Potential Liver Transplant Candidates2019; : 217 doi: 10.1007/978-3-319-92934-7_13
2
Roberto Gedaly, Felice De Stefano, Lilia Turcios, Marita Hill, Giovanna Hidalgo, Mihail I. Mitov, Michael C. Alstott, D. Allan Butterfield, Hunter C. Mitchell, Jeremy Hart, Ahmad Al-Attar, Chester D. Jennings, Francesc Marti. mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in TransplantationTransplantation 2019; 103(4): 705 doi: 10.1097/TP.0000000000002495
3
Ashley Kieran Clift, Andrea Frilling. Liver transplantation and multivisceral transplantation in the management of patients with advanced neuroendocrine tumoursWorld Journal of Gastroenterology 2018; 24(20): 2152-2162 doi: 10.3748/wjg.v24.i20.2152
4
Jong Man Kim. Can hepatocellular carcinoma recurrence be prevented after liver transplantation?Clinical and Molecular Hepatology 2021; 27(4): 562 doi: 10.3350/cmh.2021.0276
5
Rosanna Salvia, Marisa Nardiello, Carmen Scieuzo, Andrea Scala, Sabino A. Bufo, Asha Rao, Heiko Vogel, Patrizia Falabella. Novel Factors of Viral Origin Inhibit TOR Pathway Gene ExpressionFrontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01678
6
Flor Nogueras López, Patricia Abellan Alfocea, Eva Julissa Ortega Suazo, Maria Angeles López Garrido, Antonio Becerra Massare, Ana María Gila Medina, Eduardo Redondo Cerezo, M. Dolores Espinosa Aguilar. Impact of Everolimus-based Immunosuppression on Renal Function in Liver Transplant RecipientsTransplantation Proceedings 2020; 52(2): 556 doi: 10.1016/j.transproceed.2019.12.012
7
Jiajun Xu, Raghad Abdulsalam Khaleel, Haider Kamil Zaidan, Ahmed Faisal Mutee, Khaled Fahmi Fawy, Anita Gehlot, Alaa Hashim Abbas, José Luis Arias Gonzáles, Ali H Amin, Maribel Carmen Ruiz-Balvin, Shima Imannezhad, Abolfazl Bahrami, Reza Akhavan-Sigari. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networksCell Cycle 2024; : 1 doi: 10.1080/15384101.2024.2340859
8
Mustafa Nazzal, Krista L. Lentine, Abhijit S. Naik, Rosemary Ouseph, Mark A. Schnitzler, Zidong Zhang, Henry Randall, Vikas R. Dharnidharka, Dorry L. Segev, Bertram L. Kasiske, Gregory P. Hess, Tarek Alhamad, Mara McAdams-Demarco, David A. Axelrod. Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns AnalysisTransplantation Direct 2018; 4(7): e364 doi: 10.1097/TXD.0000000000000800
9
Zhan Tang, Ling Wang, Zhifang Xia, Ming Shi, Qiao Wang, Zhajun Zhan. HPLC–MS/MS-based analysis of everolimus in rabbit aqueous humor: pharmacokinetics of in situ gel eye drops of suspensionBioanalysis 2019; 11(4): 267 doi: 10.4155/bio-2018-0227
10
Giulia Mazzia, Valentina Dipace, Stefano Ponti, Sara Labanca, Simona Marenco, Giulia Pieri, Edoardo G. Giannini. LIFE-THREATENING EVEROLIMUS-ASSOCIATED EROSIVE-HEMORRHAGIC GASTROPATHY IN A LIVER TRANSPLANT PATIENTEuropean Journal of Transplantation 2023; : 1 doi: 10.57603/EJT-228
11
Mathis Wehming, Dorothée Krebs-Schmitt, Andrea Briem-Richter, Bianca Hegen, Florian Brinkert, Lutz Fischer, Enke Grabhorn. Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft RecipientsChildren 2023; 10(2): 367 doi: 10.3390/children10020367
12
Takehisa Ueno, Tasuku Kodama, Yuki Noguchi, Koichi Deguchi, Motonari Nomura, Ryuta Saka, Miho Watanabe, Yuko Tazuke, Kazuhiko Bessho, Hiroomi Okuyama. Safety and Efficacy of Everolimus Rescue Treatment After Pediatric Living Donor Liver TransplantationTransplantation Proceedings 2020; 52(6): 1829 doi: 10.1016/j.transproceed.2020.01.159
13
Ahmet Gurakar, Burcak E Tasdogan, Cem Simsek, Michelle Ma, Behnam Saberi. Update on Immunosuppression in Liver Transplantation Euroasian Journal of Hepato-Gastroenterology 2019; 9(2): 96 doi: 10.5005/jp-journals-10018-1301
14
Wenze Zhang, Zhuoxia Shen, Chaoran Li, Yumeng Yang, Tiange Zhang, Bo-Yang Yu, Xianchuang Zheng, Jiangwei Tian. A “defend–attack and capture flag” strategy for cascade management of hepatic ischemia reperfusion injuryChemical Engineering Journal 2024; 487: 150501 doi: 10.1016/j.cej.2024.150501
15
Oleksandr Kirsanov, Randall H Renegar, Jonathan T Busada, Nicholas D Serra, Ellen V Harrington, Taylor A Johnson, Christopher B Geyer. The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in the mouse†Biology of Reproduction 2020; 103(5): 1132 doi: 10.1093/biolre/ioaa130
16
Shun Manabe, Ayami Ino, Yoei Miyabe, Sekiko Taneda, Hiroshi Kataoka, Toshio Mochizuki, Kosaku Nitta. Everolimus‐associated focal segmental glomerulosclerosis in a liver transplant recipientNephrology 2021; 26(4): 371 doi: 10.1111/nep.13812
17
Seohee Lee, Jong Man Kim, Sangjin Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh. Early use of everolimus improved renal function after adult deceased donor liver transplantationKorean Journal of Transplantation 2021; 35(1): 8 doi: 10.4285/kjt.20.0043
18
Jayshri A. Shah. Peri-operative Anesthetic Management in Liver Transplantation2023; : 551 doi: 10.1007/978-981-19-6045-1_41